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Saudi Journal of Ophthalmology (2012) 26, 309–313Original ArticleDescemet stripping automated endothelial keratoplasty in pediatric
age groupqSilvana Madi, MD a,b; Paolo Santorum, MD a,c; Massimo Busin, MD a,⇑AbstractPurpose: To report the outcomes of DSAEK surgery performed in pediatric patients.
Design: Noncomparative interventional case series.
Subjects and methods: All pediatric patients (age up to 16 years) undergoing Descemet automated stripping endothelial keratopl-
asty (DSAEK) at our Institution since January 2008 have been enrolled in a prospective study. A standard DSAEK, involving delivery
of an 8.5–9.5 mm graft by Busin glide, was performed under general anesthesia in 19 eyes of 11 pediatric patients (congenital
hereditary endothelial dystrophy n = 13; congenital glaucoma n = 2; posterior polymorphous dystrophy n = 2, and failed penetrat-
ing keratoplasty n = 2). Slit-lamp examination, refraction and visual acuity as well as endothelial cell density were evaluated pre-
operatively as well as 1, 3, 6, 12, and 18 months postoperatively.
Results: All surgical procedures were uneventful. Graft detachment occurred in 4 cases and was managed successfully with repeat
air injection. All corneas cleared within a week from surgery. Follow-up was 3–18 months. At last follow-up examination, best-cor-
rected visual acuity (BCVA) was better than 20/40 in 8 of the 13 cases of patients old enough to assess vision. A graft rejection
episode was seen in 1 case within 3 months from surgery but was reverted with steroidal treatment. No graft failures were
observed.
Conclusions: DSAEK is an appropriate surgical intervention for children with corneal endothelial failure. In contrast to penetrating
keratoplasty (PK), DSAEK is performed under ‘‘closed system’’ conditions, thus minimizing intraoperative risks. Finally, healing is
much faster than with PK and all sutures can be removed within 2–4 weeks from surgery, thus allowing fast visual recovery and
prompt starting of amblyopia treatment.
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Corneal endothelial failure in pediatric age group may
be secondary to many causes, including corneal dystro-
phies,1,2 trauma, and congenital glaucoma.3 Loss of corneal
transparency by any of these etiologies causes visualPeer review under responsibility
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system.4
Until recent times penetrating keratoplasty (PK) was the
gold standard for the treatment of endothelial failure in
children. However, open-sky surgery like PK is made diffi-
cult particularly in children by the high vitreous pressureProduction and hosting by Elsevier
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310 S. Madi et al.and the low scleral rigidity of these eyes. In addition, espe-
cially in older children, sutures have to stay in place for
several months, thus requiring a rather long time for visual
rehabilitation, while exposing them to possible late suture-
related complications.4
Descemet stripping automated endothelial keratoplasty
(DSAEK) is now the standard procedure for the treatment
of corneal endothelial dysfunction in adults,5 and its use
in the pediatric age group has been described in sporadic
cases, as well as in a series of eyes with congenital hered-
itary endothelial dystrophy (CHED).5,7–10 We report here
the outcomes of DSAEK performed at our Institution in
19 eyes with endothelial failure of different etiology.Subjects and methods
We reviewed the medical records of all pediatric patients
who underwent DSAEK at our institution from January 2007
to January 2012.
All patients or legally responsible care takers provided
informed consent for the procedures performed. Analysis
of the data extracted from the medical records was per-
formed using a standard spreadsheet program. A complete
ophthalmological examination, including slitlamp examina-
tion, visual acuity and manifest refraction, applanation
tonometry, ocular motility, and funduscopy, was performed
preoperatively in all patients when possible and appropri-
ate. Visual acuity was measured by Snellen chart or assess-
ment of fixation patterns in infants. Follow-up examinations
were not possible at regular intervals at our institution, as
most patients were referred. However, each patient was
seen at our facility at least once after suture removal,
and additional information was retrieved from the referring
ophthalmologists.Figure 1. DSAEK standard technique. The procedure includes: Scoring
and stripping of the Descemet membrane using a 25-gauge bent needle
(part a); bimanual DSAEK graft delivery under continuous irrigation
through incisions shifted superiorly by 1 mm to avoid contact with the
crystalline lens (parts b and c); complete air fill at the end of the
procedure to tamponade the graft and secure attachment to the
posterior corneal surface after air-tight suturing of all incisions, including
the side entries (part d).Surgical technique
Surgery was performed using general anesthesia. The sur-
geon sat at the 12-o’clock position in all cases. DSAEK was
performed according to the standard technique described
previously and illustrated in Fig. 1.11 Descemet membrane
could not be identified in infants (age < 12 months) and
therefore was not stripped in these eyes. In all phakic eyes
(n = 16) the incisions sites were shifted 1 mm superiorly from
the standard 3 and 9 o’clock position, as shown in Fig. 1,
parts b and c. This was done to protect the crystalline lens
from accidental trauma with the instrument, while performing
the pull through maneuver for the insertion of the graft,
which was 8.5–9.5 mm in diameter.10 In the 3 aphakic eyes
venting incisions were used to drain fluid from the interface
while the air tamponade was taking place.
Postoperatively, patients were instructed to lie supine for
2 h, when possible. All patients were examined 2 h after sur-
gery at the slitlamp or again using the operating microscope,
and some air was removed when the air level failed to lie
above the inferior peripheral iridotomy by this time.
Patients were given topical tobramycin, 0.3%, and
dexamethasone, 0.1%, suspension (TobraDex; Alcon, Fort
Worth, Texas) combination therapy every 2 h after surgery;
this was reduced as clinically indicated throughout the post-
operative period. All patients were seen at days 1 and 2, as
well as week 1 after surgery. Later follow-up examinations
were scheduled at months 1, 3, 6 and 12, and were
performed elsewhere for all patients referred from other
countries.Results
Nineteen eyes of 11 patients 16-year old or younger (7
were males and 4 females) who underwent DSAEK at our
institution were identified. Patients’ age ranged from
6 months to 16 years. The average follow-up in this series
was 14.5 months (range 3–48 months). Causes of endothelial
decompensation included: CHED, Fig. 2 part a (n = 13); pos-
terior polymorphous dystrophy, Fig. 2 part c (PPD) (n = 2);
multiple intervention for congenital glaucoma, Fig. 2 part e
(n = 2); and failed PK, Fig. 2 part g (n = 2). Sixteen eyes had
clear crystalline lens at the time of presentation, 3 eyes were
aphakic. Four eyes had a history of previous ocular interven-
tion. Table 1 summarizes the demographics of population.
All surgeries were uneventful. No pupillary block was ob-
served. Graft dislocation occurred in 4 eyes (all infantile) with-
in the first two postoperative days, and was managed
successfully in all eyes by re-bubbling under general
anesthesia.
All corneas cleared by 1 week postoperatively and re-
mained so for the whole period of follow-up (Fig. 2, parts
b, d, f, and h). The only late complication observed was an
immunologic rejection episode, easily reverted with topical
and systemic steroids. No lenticular opacities were seen post-
operatively in any eye.
The outcomes of DSAEK in our pediatric population is
summarized in Table 2.
All 6 eyes of the 3 infants included in this series could fix
and follow as early as 1 week after surgery, whereas 2 of
the 6 eyes could not preoperatively. In elder children, whose
visual acuity could be assessed by means of Snellen charts,
Figure 2. Preoperative and postoperative slit-lamp pictures of eyes
undergoing DSAEK for various indications: CHED (parts a and b), PPD
(parts c and d), congenital glaucoma (parts e and f) and failed PK (parts g
and h).
Table 1. Demographic data.
Patient Eye Age/sex Diagnosis Country Lens status
1 OD 6 m/F CHED Abroad Phakic
1 OS 7 m/F CHED Abroad Phakic
2 OD 6 m/M CHED Abroad Phakic
2 OS 7 m/M CHED Abroad Phakic
3 OD 8 m/M CHED Abroad Phakic
3 OS 9 m/M CHED Abroad Phakic
4 OD 7 y/M CHED Abroad Phakic
5 OD 7 y/F CHED Abroad Phakic
5 OS 7 y/F CHED Abroad Phakic
6 OD 9 y/M CHED Abroad Phakic
6 OS 10 y/M CHED Abroad Phakic
7 OD 16 y/F CHED Italy Phakic
7 OS 16 y/F CHED Italy Phakic
8 OS 12 y/F PPD Italy Phakic
8 OD 14 y/F PPD Italy Phakic
9 OD 15 y/M Buphthalmus Italy Aphakic
9 OS 15 y/M Buphthalmus Italy Aphakic
10 OD 13 y/M Failed PK Italy Phakic
11 OS 14 y/M Failed PK Italy Aphakic
Abbreviations: m = months; y = years; M = male; F = female.
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better in 8 of 13 eyes (61.5%), of which 3 eyes (23.1%)
reached 20/20 and 2 eyes 20/25 vision. Reasons for vision
worse than 20/40 were glaucomatous damage (n = 2), ambly-
opia (n = 3).
Postoperative refractive astigmatism was within 3 Diopters
(D) in all cases (range from 0.5 to 3 D).
Endothelial cell density could be evaluated in 13 eyes. At
the time of this review, the average endothelial cell loss from
the cell count obtained at the eye bank was 35% (range from
19% to 53%).Discussion
Penetrating keratoplasty in children, especially infants, is a
challenging task. Low scleral rigidity and high intraoperative
vitreous pressure increase the surgical difficulty and may leadto vision-threatening complications, such as suprachoroidal
hemorrhage. Children are difficult to examine and are more
prone to trauma3 and infection as well as immunologic allo-
graft rejection. All of these factors may contribute to the high
incidence of graft failure reported after pediatric PK.12–14
DSAEK offers several advantages over PK in general, but
also in particular for the treatment of endothelial failure in
pediatric age. It is performed under ‘‘closed system’’ condi-
tions and therefore the risk of intraoperative complications
is minimized.10 The small corneal incision required for DSAEK
is less likely to dehisce, thus making this procedure safer than
PK especially in children, who are more exposed to trauma
than the adult population.15 Also, DSAEK sutures can be
completely removed much earlier than after PK, thus allowing
prompt treatment of amblyopia and more rapid visual
recovery.16
Only few case reports of DSAEK in pediatric age have
been published to date. Two reports concerned DSAEK in
CHED. In one of these cases DSAEK was converted into PK
due to poor visualization.7 The other article reported a suc-
cessful DSAEK in a 10 years old boy, whose vision did not im-
prove substantially due to amblyopia.17 More recently,
several children together with adults were included in a series
of DSAEK procedures performed for CHED.10 Successful
DSAEK was also reported in one child with bullous keratopa-
thy.6,8 To our knowledge this is the first series to report
DSAEK performed for various indications exclusively in pedi-
atric age.
In our study all grafts cleared within 1 week and remained
so for an average follow-up time of over 1 year. Instead, graft
failure after PK is reported in a high percentage of patients,
ranging from 18.4% to almost 50% with a follow-up period
up to 2 years.12,18–23
The most common post-PK complications possibly leading
to graft failure in children are infection, immunologic rejec-
tion and secondary glaucoma.
Infection may occur in up to 50% of children undergoing
PK and is usually related to the presence of sutures.13 In-
stead, infections were not seen in our series, probably be-
cause all sutures were removed as early as 2 weeks
postoperatively.
Table 2. DSAEK outcomes in pediatric population.
Patient Eye Preop. BCVA Graft size (mm) Postop. BCVA Refraction F/U (months) ECL at last F/U
1 OD No FF 8.5 FF FF 9 NA
1 OD No FF 8.5 FF FF 9 NA
2 OD FF 8.5 FF FF 3 NA
2 OS FF 8.5 FF FF 4 NA
3 OD FF 8.5 FF FF 4 NA
3 OS FF 8.5 FF FF 3 NA
4 OD 20/200 9.0 20/25 +7.0/+1.5  80 48 19%
5 OD 20/200 9.0 20/40 +2.0/0.5  90 18 43.0%
5 OS CF 9.0 20/70 +2.0/3.0  80 24 25.9%
6 OD 20/200 9.0 20/25 +7.0/+1.5  80 18 29.7%
6 OS CF 9.0 20/27.5 +6.0/+0.5  90 9 37.5%
7 OD 20/100 9.0 20/25 +1.5/2.0  60 24 30.5%
7 OS 20/70 9.0 20/22.5 +0.5/1.0  90 30 34.8%
8 OS 20/100 9.0 20/20 1.25  15 24 28.2%
8 OD 20/100 9.0 20/22.5 0.25/0.5  180 12 36.2%
9 OD <20/200 9.5 20/200 +10 sphere 18 53%
9 OS <20/200 9.5 20/200 +10 sphere 12 49.7%
10 OD HM 9.0 20/100 4.0/1.0  20 3 36.1%
11 OS 20/100 9.0 20/70 +10 sphere 12 36.2%
Abbreviations: BCVA = best-corrected visual acuity; CF = count fingers; HM = hand motion; ECL = endothelial cell loss; FF = fix and follow; F/U = follow-up; NA = not available.
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dren and is therefore one of the main causes for graft failure.3
Yang et al.24 observed graft rejection to be the most frequent
cause for graft failure in their series (25%), with 48% of the
rejection episodes involving the first graft. Rejection was
reversible in only 28% of episodes, showing a much lower
reversal rate in pediatric grafts compared to that of 50–
78% in adult grafts.25 In the series by Comer et al.26 53% of
the rejection episodes were not reversible and resulted in
failure. Vajpayee et al.27 also noted rejection in 22.5% of
cases with 55% of them not being reversible, and all of these
children had reported late for management. Seventeen of 19
grafts with rejection failed in the series reported by Cow-
den.22 Stulting et al.20 reported 11% of graft failures to be re-
lated to allograft rejections; whereas more than 50% of the
graft failures in the series by Dana et al.21 were attributed
to graft rejection. In contrast to this data, we observed only
1 case of immunologic rejection in our series of patients,
and it was easily reversed with steroidal treatment with a final
visual acuity of 20/20.
Finally, glaucoma has been reported in up to 16% of
post-PK pediatric patients.12,18,19 Although most of the eyes
included in our series presented normal anterior segment
anatomy, glaucoma was present in 3 of them (congenital in
2 acquired in 1). After DSAEK, none of our patients newlyTable 3. Literature review of graft failure and visual outcomes of PK in children
Paper Age
criteria
Number
of eyes
Postoperative complications
Sharma et al.18 615 y 168 Infection 28.6%. 2ry glaucoma 16.
10.11%
Al Ghamdi et al.12 612 y 165 Infection 26.6%. Glaucoma 33.3%
Graft rejection 8.48%
Aasuri et al.19 614y 154 Infection 26.9%. 2ry glaucoma 13.4
Stulting et al.20 615 y 107 NA
Dana et al.21 612 y 131 Infection 8%. Secondary glaucoma
Cowden 22 615 y 57 Graft rejection 33.3%
Patel et al.23 615 y 58 Graft rejection 10%. Primary failurdeveloped glaucoma or required intraocular pressure (IOP)
lowering medications additional to the ones used
preoperatively.
The most common postoperative complication in our
DSAEK series was graft detachment, which occurred in 4
infants of the total 19 eyes (21%). This complication is obvi-
ously unique to DSAEK, but can be easily managed success-
fully by simple air injection, as it was in all 4 cases of our
series.
Also visual results obtained after DSAEK in children com-
pare favorably with those of PK performed in the same age
group.12,18–23 Table 3 summarizes the visual outcomes of
pediatric PK in different studies published to date. Main fac-
tors affecting post-PK visual acuity in children include age at
the time of surgery and indication for surgery. Elder children
and acquired corneal disease (including keratoconus) have a
better visual prognosis than infants and congenital corneal
disorders.23 However, in general, BCVA of 20/40 or better
is seldom achieved, despite PK being often performed at
an early age. As with adults, also children usually experience
a prolonged time of visual impairment after PK, due to cor-
neal distortion secondary to the presence of sutures. In addi-
tion, high-degree astigmatism, often of the irregular type,
may persist in up to 21% of eyes even after suture removal
is completed.28 Under these conditions, treatment of ambly-.
Graft failure BCVA
F/U 12
m
F/U 24
m
P20/40 P20/200
01%. Graft rejection 13% 23% NA 30.1%
(new or pre-existing). 36.3% 49.1% 4.8% 19.4%
%. Graft rejection 42.3% NA 42.3% P20/50
23.9%
43.8%
44% NA NA NA
29%. Graft rejection 31% 20% 33% NA 33%
NA 46% NA NA
e 4% 18% NA P20/30
38%
P20/60
60%
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improve. In DSAEK the few sutures required can be removed
within 2 weeks postoperatively. In bilateral cases, this is usu-
ally done at the time of the second eye undergoing DSAEK.
The optical correction of the residual refractive error can be
prescribed as early as one month postoperatively and ambly-
opia treatment started. In addition, as opposed to PK, spec-
tacle correction is possible in all cases, as the final
astigmatism is of the regular type and low in absolute value.
In our series, we did not observe any post-DSAEK astigmatic
error higher than 3.0 D. As a result, 8 of 13 eyes (61.5%) of
our verbal patients enjoyed 20/40 BCVA or better, with 3
of 13 eyes (23.1%) seeing 20/20.
It is certainly difficult to compare trials directly, given
the differences in patient ages and disease severity and/
or amblyopia as well as the differing proportions of pa-
tients being of verbal age and therefore able to comply
with visual acuity testing.12,18–23 However, based on our
experience DSAEK has proven superior to conventional
PK in terms of safety and efficacy for the treatment of
endothelial decompensation in the pediatric age group. If
our preliminary data will be confirmed in a larger number
of patients followed for a prolonged period of time,
DSAEK surgery will soon replace conventional PK also in
the pediatric population.Financial disclosure
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